Literature DB >> 6392316

Association of Pseudomonas maltophilia with malignant lesions.

T Nagai.   

Abstract

Infections caused by nonfermentative, gram-negative, rod-shaped bacteria (NFGNR) in 564 patients were reviewed. For comparison, 227 patients with Serratia marcescens infections were also studied. Among the patients with NFGNR infections, 24% had some form of malignant solid tumor, and 9% had leukemia and lymphoma. Among the patients with S. marcescens infections, 22% had some type of malignant solid tumor, and 8% had leukemia and lymphoma. The frequency of various species of NFGNR (except Pseudomonas maltophilia and S. marcescens) in patients with a malignancy at the site from which the specimens had been obtained was 5 to 24%. However, 39 of 82 patients (48%) with P. maltophilia infections had a malignancy at the site from which P. maltophilia had been isolated. There were significantly more P. maltophilia infections at the sites of malignant lesions than there were other NFGNR or S. marcescens infections (P less than 0.05).

Entities:  

Mesh:

Year:  1984        PMID: 6392316      PMCID: PMC271497          DOI: 10.1128/jcm.20.5.1003-1005.1984

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  16 in total

1.  [Pseudomonas infections].

Authors:  H Schäfer
Journal:  Dtsch Med Wochenschr       Date:  1975-08-22       Impact factor: 0.628

2.  Pseudomonas bacteremia in patients with malignant diseases.

Authors:  J P Whitecar; M Luna; G P Bodey
Journal:  Am J Med Sci       Date:  1970-10       Impact factor: 2.378

3.  Infrequently encountered Pseudomonas species causing infection in humans.

Authors:  G L Gilardi
Journal:  Ann Intern Med       Date:  1972-08       Impact factor: 25.391

4.  Characterization of saccharolytic nonfermentative bacteria associated with man.

Authors:  M J Pickett; M M Pedersen
Journal:  Can J Microbiol       Date:  1970-05       Impact factor: 2.419

5.  Nonfermentative gram-negative bacilli of nosocomial interest.

Authors:  P Gardner; W B Griffin; M N Swartz; L J Kunz
Journal:  Am J Med       Date:  1970-06       Impact factor: 4.965

6.  Nonpigmented Serratia marcescens.

Authors:  E Clayton; A Von Graevenitz
Journal:  JAMA       Date:  1966-09-26       Impact factor: 56.272

7.  Epidemiological studies of Pseudomonas species in patients with leukemia.

Authors:  G P Bodey
Journal:  Am J Med Sci       Date:  1970-08       Impact factor: 2.378

8.  Pseudomonas maltophilia infections in man.

Authors:  G L Gilardi
Journal:  Am J Clin Pathol       Date:  1969-01       Impact factor: 2.493

9.  Clostridium septicum infections and malignancy.

Authors:  R J Alpern; V R Dowell
Journal:  JAMA       Date:  1969-07-21       Impact factor: 56.272

10.  Pseudomonas aeruginosa bacteremia in patients with neoplastic disease.

Authors:  L S Fishman; D Armstrong
Journal:  Cancer       Date:  1972-09       Impact factor: 6.860

View more
  8 in total

1.  Pseudo-, Xantho-, and now Stenotrophomonas maltophilia: New kid on the block.

Authors:  J Conly; S Shafran
Journal:  Can J Infect Dis       Date:  1996-03

2.  Identification and detection of Stenotrophomonas maltophilia by rRNA-directed PCR.

Authors:  P W Whitby; K B Carter; J L Burns; J A Royall; J J LiPuma; T L Stull
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

3.  A new selective differential medium for isolation of Stenotrophomonas maltophilia.

Authors:  K G Kerr; M Denton; N Todd; C M Corps; P Kumari; P M Hawkey
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-07       Impact factor: 3.267

4.  Serological classification of Xanthomonas maltophilia (Pseudomonas maltophilia) based on heat-stable O antigens.

Authors:  B Schable; D L Rhoden; R Hugh; R E Weaver; N Khardori; P B Smith; G P Bodey; R L Anderson
Journal:  J Clin Microbiol       Date:  1989-05       Impact factor: 5.948

Review 5.  Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia.

Authors:  M Denton; K G Kerr
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

6.  Activities of three quinolones, alone and in combination with extended-spectrum cephalosporins or gentamicin, against Stenotrophomonas maltophilia.

Authors:  M A Visalli; M R Jacobs; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  1998-08       Impact factor: 5.191

7.  Susceptibilities of 123 strains of Xanthomonas maltophilia to eight beta-lactams (including beta-lactam-beta-lactamase inhibitor combinations) and ciprofloxacin tested by five methods.

Authors:  G A Pankuch; M R Jacobs; S F Rittenhouse; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  1994-10       Impact factor: 5.191

8.  Associated mortality and clinical characteristics of nosocomial Pseudomonas maltophilia in a university hospital.

Authors:  A J Morrison; K K Hoffmann; R P Wenzel
Journal:  J Clin Microbiol       Date:  1986-07       Impact factor: 5.948

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.